Triple

T21206813
Position Surface form Disambiguated ID Type / Status
Subject John Stuelpnagel E522606 entity
Predicate boardMemberOf P10 FINISHED
Object Fabric Genomics — NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Fabric Genomics | Statement: [John Stuelpnagel, boardMemberOf, Fabric Genomics]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Fabric Genomics
Context triple: [John Stuelpnagel, boardMemberOf, Fabric Genomics]
  • A. Nebula Genomics
    Nebula Genomics is a personal genomics company that offers whole-genome sequencing and analysis with a focus on privacy-preserving, blockchain-based data sharing.
  • B. Edico Genome
    Edico Genome was a biotechnology company specializing in high-speed genomic data analysis through its DRAGEN bio-IT platform and FPGA-based acceleration technology.
  • C. Genocea Biosciences
    Genocea Biosciences is a biotechnology company that develops T cell–targeted vaccines and immunotherapies using a proprietary antigen discovery platform.
  • D. Pacific Biosciences
    Pacific Biosciences is a biotechnology company specializing in advanced DNA sequencing technologies, particularly long-read sequencing platforms used in genomics research.
  • E. Horizon Discovery
    Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Fabric Genomics
Target entity description: Fabric Genomics is a precision medicine and clinical genomics company that provides software and analytics to interpret genomic data for healthcare and research institutions.
  • A. Nebula Genomics
    Nebula Genomics is a personal genomics company that offers whole-genome sequencing and analysis with a focus on privacy-preserving, blockchain-based data sharing.
  • B. Edico Genome
    Edico Genome was a biotechnology company specializing in high-speed genomic data analysis through its DRAGEN bio-IT platform and FPGA-based acceleration technology.
  • C. Genocea Biosciences
    Genocea Biosciences is a biotechnology company that develops T cell–targeted vaccines and immunotherapies using a proprietary antigen discovery platform.
  • D. Pacific Biosciences
    Pacific Biosciences is a biotechnology company specializing in advanced DNA sequencing technologies, particularly long-read sequencing platforms used in genomics research.
  • E. Horizon Discovery
    Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b5112d8881909510b2dcdc93106d completed April 16, 2026, 10:08 a.m.
NER Named-entity recognition batch_69e73435322c8190bf4156fbd14edc5c completed April 21, 2026, 8:24 a.m.
Created at: April 16, 2026, 3:24 p.m.